Product Information

CARVEDILOL 12.5 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0209 per EA under NDC 82009012705. Its NADAC has been published 159 times since Nov 8, 2023.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 12.5 MG TABLET

Carvedilol
$0.0209per EA

Strength

12.5 mg/1

NDC

82009012705

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA077614

FDA Approved

9/5/2007

TE Code

AB

On Market Since

8/3/2023

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 12.5 MG TABLET has been published 159 times since Nov 8, 2023, and over the history we have for it it has declined 8.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0209 per EA
All-time high$0.0231 (Mar 13, 2024)
All-time low$0.0184 (Nov 20, 2024)
52-week high$0.0216
52-week low$0.0209
Median price$0.0216
Average price$0.0214
Largest weekly change-18.1% (Nov 20, 2024)
Weeks tracked159
Tracking sinceNov 8, 2023

Price History

1W

-1.8%

1M

-3.3%

3M

-2.3%

6M

-0.7%

1Y

-2.9%

3Y

-8.7%

5Y

N/A

All

-8.7%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARVEDILOL 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 12.5 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0209 per EA (NDC 82009012705), effective Nov 18, 2026.

How has the price of CARVEDILOL 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 12.5 MG TABLET has declined 8.7%. It has been tracked across 159 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 12.5 MG TABLET?

Since Nov 8, 2023, the NADAC for CARVEDILOL 12.5 MG TABLET has ranged from a low of $0.0184 (Nov 20, 2024) to a high of $0.0231 (Mar 13, 2024), with a median of $0.0216 per EA.

Are there cheaper alternatives to CARVEDILOL 12.5 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 12.5 MG TABLET?

CARVEDILOL 12.5 MG TABLET (NDC 82009012705) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.